Detection of Specific IgE Antibodies to Nafamostat Mesilate as an Indication of Possible Adverse Effects of Leukocytapheresis using Nafamostat Mesilate as Anticoagulant-Reference-Cited by-同舟云学术

Detection of Specific IgE Antibodies to Nafamostat Mesilate as an Indication of Possible Adverse Effects of Leukocytapheresis using Nafamostat Mesilate as Anticoagulant

Published:2004-02 Issue:1 Volume:8 Page:45-51
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Therapher Dial

Author:

Nagase Kazuko,Fukunaga Ken,Ohnishi Kunio,Kusaka Takeshi,Matoba Yoshika,Sawada Koji

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1526-0968.2004.00086.x/fullpdf

Reference25 articles.

1. Pharmacological Studies of FUT-175, Nafamstat Mesilate I. Inhibition of Protease Activity in in Vitro and in Vivo Experiments

2. New synthetic inhibitors of C1r̄, C1 esterase, thrombin, plasmin, kallikrein and trypsin

3. Nafamostat Mesilate: A Regional Anticoagulant for Hemodialysis in Patients at High Risk for Bleeding

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for allergic reaction at initial therapeutic plasma exchange in a single-center study: beware of high rates of severe allergic reaction;Renal Replacement Therapy;2016-12

2. Cardiac arrest caused by nafamostat mesilate;Kidney Research and Clinical Practice;2016-09

3. Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis;Modern Rheumatology;2014-02-11

4. Reduction in bradykinin generation during leukocytapheresis using novel cellsorbaTMCS-180S: Effects of changing the filling solution;Journal of Clinical Apheresis;2013-09-11

5. Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis;Journal of the American Academy of Dermatology;2013-04